Norbert Vey

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Venues

Institut Paoli-Calmettes

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut Paoli-Calmettes

France

Head of the Leukemia and MDS Program/Pr :: Hematology

Publications

Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Jean-Marie Boher, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Norbert Vey, Cécile Bannier-Braticevic
Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study. BMJ open 14 (3) (2024)
Florence Rabian, Sylvie Chevret, Bérengère Gruson, Sylvain Thépot, Anouk Walter-Petrich, Thorsten Braun, Norbert Vey, José Miguel Torregrosa-Diaz, Pierre Peterlin, Andrea Toma, Maud D'Aveni, Jacques Delaunay, Laurence Legros, Nathalie Droin, Fatiha Chermat, Daniel Lusina, Lionel Ades, Rosa Sapena, Eric Solary, Pierre Fenaux, Raphaël A Itzykson
Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study. Leukemia (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerlé, Samuel Granjeaud, Jean-François Hamel, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances 8 (16) (2024)
Sylvain Garciaz, Marie-Anne Hospital, Yves Collette, Norbert Vey
Venetoclax Resistance in Acute Myeloid Leukemia. Cancers 16 (6) (2024)
Julien M P Grenier, Céline Testut, Matthieu Bal, Florence Bardin, Maria De Grandis, Véronique Gelsi-Boyer, Julien Vernerey, Marjorie Delahaye, Samuel Granjeaud, Christophe Zemmour, Jean-François Spinella, Triantafyllos Chavakis, Stéphane J C Mancini, Jean-Marie Boher, Josée Hébert, Guy Sauvageau, Norbert Vey, Juerg Schwaller, Marie-Anne Hospital, Cyril Fauriat, Michel A Aurrand-Lions
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML. Blood advances 8 (17) (2024)
Julien M P Grenier, Céline Testut, Matthieu Bal, Florence Bardin, Maria De Grandis, Véronique Gelsi-Boyer, Julien Vernerey, Marjorie Delahaye, Samuel Granjeaud, Christophe Zemmour, Jean-François Spinella, Triantafyllos Chavakis, Stéphane J C Mancini, Jean-Marie Boher, Josée Hébert, Guy Sauvageau, Norbert Vey, Juerg Schwaller, Marie-Anne Hospital, Cyril Fauriat, Michel A Aurrand-Lions
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML. Blood advances 8 (17) (2024)
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Chantal Himberlin, Pierre Peterlin, Sarah Bonnet, Onyee Chan, Jeffrey E Lancet, Rami Komrokji, François Vergez, Nicolas Chapuis, Tatiana Raskovalova, Adriana Plesa, Anne-Catherine Lhoumeau, Ariane Mineur, Marie Anne Hospital, Arnaud Pigneux, Norbert Vey, Christian Recher
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. American journal of hematology (2024)
Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Jean-Marie Boher, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Norbert Vey, Cécile Bannier-Braticevic
Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study. BMJ open 14 (3) (2024)
Sylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, David A Sallman, Justine Decroocq, Amine Belhabri, Corentin Orvain, Gaspar Aspas Requena, Celestine Simand, Kamel Laribi, Martin Carré, Alberto Santagostino, Chantal Himberlin, Pierre Peterlin, Sarah Bonnet, Onyee Chan, Jeffrey E Lancet, Rami Komrokji, François Vergez, Nicolas Chapuis, Tatiana Raskovalova, Adriana Plesa, Anne-Catherine Lhoumeau, Ariane Mineur, Marie Anne Hospital, Arnaud Pigneux, Norbert Vey, Christian Recher
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment. American journal of hematology (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerle, Samuel Granjeaud, Jean-François Hamel-Broza, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T-cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances (2024)
Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Jean-Marie Boher, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Norbert Vey, Cécile Bannier-Braticevic
Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study. BMJ open 14 (3) (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerlé, Samuel Granjeaud, Jean-François Hamel, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances 8 (16) (2024)
Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Jean-Marie Boher, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Norbert Vey, Cécile Bannier-Braticevic
Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study. BMJ open 14 (3) (2024)
Julien M P Grenier, Céline Testut, Matthieu Bal, Florence Bardin, Maria De Grandis, Véronique Gelsi-Boyer, Julien Vernerny, Marjorie C Delahaye, Samuel Granjeaud, Christophe Zemmour, Jean-François Spinella, Triantafyllos Chavakis, Stephane Jc Mancini, Jean-Marie Boher, Josée Hébert, Guy Sauvageau, Norbert Vey, Juerg Schwaller, Marie-Anne Hospital, Cyril Fauriat, Michel A Aurrand-Lions
Genetic deletion of JAM-C in pre-leukemic cells rewires leukemic stem cell gene expression program in AML. Blood advances (2024)
Anne CharlotteLe Floch Le Floch, Caroline Imbert, Nicolas Boucherit, Laurent Gorvel, Stéphane Fattori, Florence Orlanducci, Aude Le Roy, Lorenzo Archetti, Lydie Crescence, Laurence Panicot-Dubois, Christophe Dubois, Norbert Vey, Antoine Briantais, Amandine Anastasio, Carla Cano, Geoffrey C Guittard, Mathieu Frechin, Daniel Olive
Targeting BTN2A1 enhances Vγ9Vδ2 T-cell effector functions and triggers tumor cell pyroptosis. Cancer immunology research (2024)
Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Jean-Marie Boher, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Norbert Vey, Cécile Bannier-Braticevic
Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell transplantation (COHABILIT): protocol for an innovating prospective multicentre study. BMJ open 14 (3) (2024)
Sylvain Garciaz, Marie-Anne Hospital, Yves Collette, Norbert Vey
Venetoclax Resistance in Acute Myeloid Leukemia. Cancers 16 (6) (2024)
Robin Noel, Christophe Zemmour, Catalina Montes de Oca, Nawel Belmecheri, Thérèse Aurran-Schleinitz, Diane Coso, Leonor Lopez Almeida, Lénaïg Mescam, Norbert Vey, Jean Sébastien Bladé, Borhane Slama, Reda Bouabdallah, Jean-Marc Schiano de Colella
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Raphael Leblanc, Rania Ghossoub, Armelle Goubard, Rémy Castellano, Joanna Fares, Luc Camoin, Stephane Audebert, Marielle Balzano, Berna Bou-Tayeh, Cyril Fauriat, Norbert Vey, Sylvain Garciaz, Jean-Paul Borg, Yves Collette, Michel A Aurrand-Lions, Guido David, Pascale Zimmermann
Downregulation of stromal syntenin sustains AML development. EMBO molecular medicine (2023)
Anne CharlotteLe Floch Le Floch, Marie-Sarah Rouvière, Nassim Salem, Amira Ben Amara, Florence Orlanducci, Norbert Vey, Laurent Gorvel, Anne-Sophie Chretien, Daniel Olive
Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells. Cells 12 (13) (2023)
Andrew M Brunner, Jordi Esteve, Kimmo Porkka, Steve Knapper, Elie Traer, Sebastian Scholl, Guillermo Garcia Manero, Norbert Vey, Martin Wermke, Jeroen J W M Janssen, Rupa Narayan, Shaun Fleming, Sun Loo, Natalia Tovar, Mika Kontro, Oliver G Ottmann, Purushotham Naidu, Haiying Sun, May Han, Roisin White, Na Zhang, Anisa Mohammed, Catherine A Sabatos-Peyton, David P Steensma, Mikael L Rinne, Uma M Borate, Andrew H Wei
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes. American journal of hematology (2023)
François Dachy, Sabine Furst, Boris Calmels, Thomas Pagliardini, Samia Harbi, Benjamin Bouchacourt, Anne Calleja, Claude Lemarie, Aude Collignon, Guillaume Morel, Faezeh Legrand, Elena Bekrieva, Angela Granata, Pierre Jean Weiller, Christian Chabanon, Jean Marc Schiano De Colella, Norbert Vey, Didier Blaise, Raynier Devillier
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Lionel Ades, Nicolas Duployez, Agnes Guerci-Bresler, Kamel Laribi, Pierre Peterlin, Norbert Vey, Sylvain Thepot, Stefan Wickenhauser, Hacene Zerazhi, Aspassia Stamatoullas, Eric Wattel, Christian Recher, Andrea Toma, Sophie Dimicoli-Salazar, Thorsten Braun, Odile Beyne-Rauzy, Jean-Pierre Marolleau, Stéphane Cheze, Sophie Park, Thomas Cluzeau, Stanislas Nimubona, Dominique Bordessoule, Riad Benramdane, Bruno Quesnel, Shanti Amé, Stéphane de Botton, Fathia Chermat, Claude Preudhomme, Sylvie Chevret, Pierre Fenaux
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations. British journal of haematology 198 (3) (2022)
Marina Y Konopleva, Christoph Röllig, Jamie Cavenagh, Dries Deeren, Larisa Girshova, Jürgen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas A Schäfer, Oliver Gerhard Ottmann, Mario Petrini, Arnaud Pigneux, Alessandro Rambaldi, Christian Recher, Rebeca Rodriguez-Veiga, David Taussig, Norbert Vey, Sung Soo Yoon, Marion Ott, Susanne Muehlbauer, Benjamin M Beckermann, Olivier Catalani, Magali Genevray, Kirsten Mundt, Candice Jamois, Pierre Fenaux, Andrew H Wei
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial. Blood advances 6 (14) (2022)
Pierre-Nicolas Bris, Philippe Gauchez, Raynier Devillier, Lionel Galicier, Aude Collignon, Gilles Piana, Flora Poizat, Marion Faucher, Marie-Anne Hospital, Norbert Vey, Frederic Gonzalez, Luca Servan, Laurent Chow-Chine, Antoine Sannini, Djamel Mokart, Colombe Saillard, Magali Bisbal
Hepatic haemophagocytosis in haematology patients with hepatic dysfunction: prognostic impact and contribution of liver biopsy combined with the haemophagocytic syndrome diagnostic score (HScore). British journal of haematology 199 (1) (2022)
Arsenne Mekinian, Lin-Pierre Zhao, Sylvie Chevret, Kristell Desseaux, Laurent Pascal, Thibaut Comont, Alexandre Maria, Pierre Peterlin, Louis Terriou, Maud D'Aveni Piney, Marie-Pierre Gourin, Norbert Vey, Odile Beyne Rauzy, Vincent Grobost, Holy Bezanahary, Sophie Dimicoli-Salazar, Anne Banos, Stefan Wickenhauser, Benoit De Renzis, Eric Durot, Shanti Natarajan-Amé, Laurent Voillat, Fatiha Chermat, Karine Lemaire, Vincent Jachiet, Chantal Himberlin, Sylvain Thépot, Jose Miguel Torregrosa Diaz, Laurent Frenzel, Emmanuel Gyan, Guillaume Denis, Pierre Hirsch, Olivier Kosmider, Lionel Ades, Olivier Fain, Pierre Fenaux
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML. Leukemia 36 (11) (2022)
Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini, Daniel A Pollyea, Agostino Tafuri, Joseph M Brandwein, Arnaud Pigneux, Bayard L Powell, Pierre Fenaux, Rebecca L Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion G Ott, Wan-Jen Hong, Marina Y Konopleva, Michael Andreeff
Venetoclax and idasanutlin in relapsed/refractory AML: a non-randomized, open-label phase 1b trial. Blood (2022)
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, Colombe Saillard, Yosr Hicheri, Bilal Mohty, Jérôme Rey, Evelyne D'Incan, Aude Charbonnier, Ferdinand Villetard, Valerio Maisano, Laura Lombardi, Antoine Ittel, Marie-Joelle Mozziconacci, Véronique Gelsi-Boyer, Norbert Vey
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients. Cancers 14 (8) (2022)
Justine Decroocq, Rudy Birsen, Camille Montersino, Prasad Chaskar, Jordi Mano, Laury Poulain, Chloe Friedrich, Anne-Sophie Alary, Hélène Guermouche, Ambrine Sahal, Guillemette Fouquet, Mathilde Gotanègre, Federico Simonetta, Sarah Mouche, Pierre Gestraud, Auriane Lescure, Elaine Del Nery, Claudie Bosc, Adrien Grenier, Fetta Mazed, Johanna Mondesir, Nicolas Chapuis, Liza Ho, Aicha Boughalem, Marc Lelorc'h, Camille Gobeaux, Michaela Fontenay, Christian Recher, Norbert Vey, Arnaud Guillé, Daniel Birnbaum, Olivier Hermine, Isabelle Radford-Weiss, Petros Tsantoulis, Yves Collette, Rémy Castellano, Jean-Emmanuel Sarry, Éric Pasmant, Didier Bouscary, Olivier Kosmider, Jérome Tamburini
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia. Leukemia 36 (5) (2022)
Thomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, Aurore Touzart, Mathieu Simonin, Johanna Mondesir, Ludovic Lhermitte, Jonathan Bond, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Isabelle Arnoux, Virginie Gandemer, Marie Balsat, Norbert Vey, Elizabeth A Macintyre, Norbert Ifrah, Hervé Dombret, Arnaud Petit, André Baruchel, Philippe Ruminy, Nicolas Boissel, Vahid Asnafi
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins. Blood cancer journal 12 (1) (2022)
Raynier Devillier, Edouard Forcade, Alice Garnier, Sarah Guenounou, Sylvain Thépot, Gaelle Guillerm, Patrice Ceballos, Yosr Hicheri, Pierre-Yves Dumas, Pierre Peterlin, Mathilde M Hunault-Berger, Marie Christine Bene, Anne Bouvier, Patrice Chevallier, Didier Blaise, Norbert Vey, Arnaud Pigneux, Christian Recher, Anne Huynh
In-depth time-dependent analysis of the benefit of Allo-HSCT for elderly patients with CR1 AML: a FILO study. Blood advances (2021)
Laetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, Pierre-Yves Dumas, Naïs Prade, Stéphanie Dufrechou, Julien Plenecassagnes, Isabelle Luquet, Odile Blanchet, Anne Banos, Marie Christine Bene, Marc Bernard, Sarah Bertoli, Caroline Bonmati, Luc Matthieu Fornecker, Romain Guièze, Lamya Haddaoui, Mathilde Hunault, Jean Christophe Ianotto, Eric Jourdan, Mario Ojeda, Pierre Peterlin, Norbert Vey, Hacene Zerazhi, Hicheri Yosr, Ariane Mineur, Jean-Yves Cahn, Norbert Ifrah, Christian Recher, Arnaud Pigneux, Eric Delabesse, null null
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study. Leukemia 35 (5) (2020)
Norbert Vey
Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia. Therapeutic advances in hematology 11 (2020)

Norbert Vey.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Norbert Vey